The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Ultragenyx Pharmaceutical Inc shares valued at $495,231 were sold by KAKKIS EMIL D on Dec 30 ’24. At $42.23 per share, KAKKIS EMIL D sold 11,727 shares. The insider’s holdings dropped to 2,183,985 shares worth approximately $99.09 million following the completion of this transaction.
Also, KAKKIS EMIL D purchased 11,727 shares, netting a total of over 495,264 in proceeds.
Before that, KAKKIS EMIL D had sold 8,273 shares from its account. In a trade valued at $413,650, the President & CEO traded Ultragenyx Pharmaceutical Inc shares for $50.00 each. Upon closing the transaction, the insider’s holdings decreased to 8,273 shares, worth approximately $99.62 million.
As published in a research note from Goldman on June 06, 2024, Ultragenyx Pharmaceutical Inc [RARE] has been rated up from a Neutral to a Buy and the price target has been revised to $67 from $56. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in late April. As of December 08, 2023, Wells Fargo has initiated its “an Overweight” rating for RARE.
Analyzing RARE Stock Performance
During the last five days, there has been a surge of approximately 6.83%. Over the course of the year, Ultragenyx Pharmaceutical Inc shares have jumped approximately 7.84%. Shares of the company reached a 52-week high of $46.24 on 01/07/25 and a 52-week low of $39.79 on 01/14/25. A 50-day SMA is recorded $44.46, while a 200-day SMA reached $47.23. Nevertheless, trading volume fell to 0.55 million shares from 0.5 million shares the previous day.
Support And Resistance Levels for Ultragenyx Pharmaceutical Inc (RARE)
According to the 24-hour chart, there is a support level at 44.49, which, if violated, would cause prices to drop to 43.62. In the upper region, resistance lies at 45.94. The next price resistance is at 46.51. RSI (Relative Strength Index) is 58.13 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.35, which suggests the price will increase in the coming days. Percent R is at 4.69%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
